PharVision Advisers’s The Gap Inc GAP Stock Holding History

PharVision Advisers’s Portfolio GAP Stock Details GAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,572	Closed	-$245K	–	678
2025 Q4	$245K	Buy	+9,572	New	+$232K	0.12%	406

Other funds holding GAP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's GAP Position: Q1 2026 in Review

PharVision Advisers sold out of The Gap Inc (GAP) in Q1 2026, closing a stake of 9,572 shares — an estimated $245K sold.

PharVision Advisers first reported a position in GAP in Q4 2025 and held it in 1 quarter. The position peaked at $245K in Q4 2025. 492 funds tracked by Wall St. Rank hold GAP as of Q1 2026.

PharVision Advisers reported no remaining The Gap Inc position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 9,572 The Gap Inc shares in Q1 2026, an estimated $245K.
PharVision Advisers first reported a position in The Gap Inc in Q4 2025 and held it in 1 quarter.
PharVision Advisers's The Gap Inc position peaked at $245K in Q4 2025.
492 funds tracked by Wall St. Rank held The Gap Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.